文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

中性粒细胞CD64、IL-6和PCT对ICU脓毒症患者的诊断和预后价值

[Diagnostic and prognostic value of neutrophil CD64, IL-6, and PCT in ICU patients with sepsis].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2023-01-01
一句话结论nCD64、IL-6和PCT对脓毒症诊断均有较好价值,nCD64最高,三者联合诊断价值最高;清除率越高,28天死亡风险越低。

前瞻性研究纳入青岛大学附属烟台毓璜顶医院西区ICU 2020年9月至2021年10月收治的成人患者,入ICU 6小时内采血测nCD64、IL-6、PCT,第3、7天复测。最终纳入脓毒症47例、脓毒性休克43例、非脓毒症41例;28天存活76例、死亡14例。脓毒症组入ICU第1天nCD64、IL-6、PCT均显著高于非脓毒症组(均P<0.01);诊断脓毒症的AUC分别为0.945、0.792、0.888,nCD64最高,cut-off 7.45时敏感度92.2%、特异度95.1%;三者联合AUC 0.973、敏感度92.2%、特异度97.6%。脓毒性休克组第1、3、7天三项指标均高于脓毒症组,评估严重程度AUC 0.682~0.777;死亡组各时间点指标显著高于存活组(除入ICU第1天nCD64和PCT外,其余时间点差异均有统计学意义),预测预后AUC 0.600~0.981。第3、7天nCD64、IL-6、PCT清除率是脓毒症患者28天死亡的保护因素(第7天IL-6清除率除外)。

要点

  • 脓毒症组入ICU第1天nCD64 26.95(14.05, 86.18)vs 非脓毒症组3.10(2.55, 5.10),IL-6 93.45(52.73, 246.30)ng/L vs 34.00(9.76, 62.75)ng/L,PCT 6.63(0.57, 68.50)μg/L vs 0.16(0.08, 0.35)μg/L,均P<0.01。
  • 诊断脓毒症nCD64的AUC 0.945最高,cut-off 7.45时敏感度92.2%、特异度95.1%;三者联合AUC 0.973、敏感度92.2%、特异度97.6%。
  • 脓毒性休克组入ICU第1、3、7天nCD64、IL-6、PCT均高于脓毒症组,评估严重程度AUC 0.682~0.777。
  • 死亡组nCD64、IL-6、PCT显著高于存活组,除入ICU第1天nCD64和PCT外其余时间点差异有统计学意义,预测预后AUC 0.600~0.981。
  • 第3、7天nCD64、IL-6、PCT清除率是脓毒症患者28天死亡的保护因素(第7天IL-6清除率除外),清除率越高28天死亡风险越低。

适用人群与场景

  • 青岛大学附属烟台毓璜顶医院西区ICU 2020年9月至2021年10月收治的成人患者,入ICU 6小时内采集静脉血。
  • 按Sepsis-3诊断标准分为脓毒症组与非脓毒症组;脓毒症患者按入ICU时病情分为脓毒症组与脓毒性休克组;按28天生存情况分为存活组与死亡组。

诊断标准与关键阈值

  • 采用Sepsis-3诊断标准将患者分为脓毒症组和非脓毒症组。
  • nCD64诊断脓毒症的cut-off值为7.45,敏感度92.2%、特异度95.1%。

研究设计与关键结果

  • 前瞻性研究最终纳入脓毒症47例、脓毒性休克43例、非脓毒症41例;脓毒症患者28天存活76例、死亡14例。
  • 脓毒症组入ICU第1天nCD64、IL-6、PCT显著高于非脓毒症组:nCD64 26.95(14.05, 86.18)vs 3.10(2.55, 5.10),IL-6 93.45(52.73, 246.30)ng/L vs 34.00(9.76, 62.75)ng/L,PCT 6.63(0.57, 68.50)μg/L vs 0.16(0.08, 0.35)μg/L,均P<0.01。
  • 诊断脓毒症AUC:nCD64 0.945、IL-6 0.792、PCT 0.888,nCD64诊断价值最高;nCD64 cut-off 7.45时敏感度92.2%、特异度95.1%。
  • 两两联合或三者联合诊断时,三者联合诊断效能最高,AUC 0.973、敏感度92.2%、特异度97.6%。
  • 脓毒性休克组入ICU第1、3、7天nCD64、IL-6、PCT均高于脓毒症组;ROC分析显示三项指标在入ICU第1、3、7天评估脓毒症严重程度有一定准确性,AUC 0.682~0.777。
  • 死亡组nCD64、IL-6、PCT显著高于存活组;除入ICU第1天nCD64和PCT外,其余时间点两组各指标差异均有统计学意义;预测脓毒症预后AUC 0.600~0.981。
  • 以入ICU第1天与第3天或第7天差值除以第1天值计算第3、7天nCD64、IL-6、PCT清除率;Logistic回归显示第3、7天nCD64、IL-6、PCT清除率是脓毒症患者28天死亡的保护因素,第7天IL-6清除率除外。

证据类型、等级与局限

  • 证据类型:前瞻性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为nCD64、IL-6、PCT作为生物标志物对脓毒症诊断有良好价值,nCD64诊断价值高于PCT和IL-6,三者联合诊断价值最高。
  • 作者认为nCD64、IL-6、PCT对评估脓毒症严重程度和预测预后有一定价值。
  • 作者认为nCD64、IL-6、PCT清除率越高,脓毒症患者28天死亡风险越低。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the significance of neutrophil CD64 (nCD64), interleukin-6 (IL-6), and procalcitonin (PCT) alone and in combination in the diagnosis and prognosis evaluation of patients with sepsis.

METHODS: A prospective study was conducted. Adult patients admitted to the Western Intensive Care Unit (ICU) of Yantai Yuhuangding Hospital Affiliated to Medical College of Qingdao University from September 2020 to October 2021 were selected as subjects. The venous blood of the selected patients was collected within 6 hours of entering the ICU to measure the levels of nCD64, IL-6 and PCT. The levels of nCD64, IL-6 and PCT of septic patients were measured again on the 3rd and 7th days after admission to ICU. According to the diagnostic criteria of Sepsis-3, the patients were divided into sepsis group and non-sepsis group to evaluate the diagnostic value of nCD64, IL-6 and PCT in sepsis. The patients with sepsis were divided into sepsis group and septic shock group according to their condition on admission to ICU, and the evaluation value of three biomarkers for sepsis was evaluated. Sepsis patients were divided into the survival group and the death group according to survival after 28 days, and the relationship between the three biomarkers and the prognosis of sepsis was evaluated.

RESULTS: Finally, 47 patients with sepsis, 43 patients with septic shock, and 41 patients without sepsis were enrolled. Seventy-six patients with sepsis survived and 14 died after 28 days. (1) The levels of nCD64, IL-6 and PCT on the first day of ICU admission in the sepsis group were significantly higher than those in the non-sepsis group [nCD64: 26.95 (14.05, 86.18) vs. 3.10 (2.55, 5.10), IL-6 (ng/L): 93.45 (52.73, 246.30) vs. 34.00 (9.76, 62.75), PCT (μg/L): 6.63 (0.57, 68.50) vs. 0.16 (0.08, 0.35), all P < 0.01]. The receiver operator characteristic curve (ROC curve) showed that the area under curve (AUC) of nCD64, IL-6 and PCT in the diagnosis of sepsis were 0.945, 0.792 and 0.888, respectively. The diagnostic value of nCD64 was the highest. When the cut-off value of nCD64 was 7.45, the sensitivity and specificity were 92.2% and 95.1% respectively. When nCD64, IL-6 and PCT were diagnosed in pairs or in combination, the combination of the three had the highest diagnostic performance, with AUC of 0.973, sensitivity of 92.2% and specificity of 97.6%. (2) The levels of nCD64, IL-6 and PCT in septic shock group were higher than those in sepsis group on the 1st, 3rd and 7th day after admission to ICU. ROC curve analysis showed that nCD64, IL-6 and PCT had some accuracy in evaluating the severity of sepsis on the 1st, 3rd and 7th day after entering ICU, with AUC ranging from 0.682 to 0.777. (3) The levels of nCD64, IL-6 and PCT in the death group were significantly higher than those in the survival group. Except for the nCD64 and PCT values on the first day after admission to the ICU, there were significant differences between the two groups in all indicators at other time points. ROC curve analysis showed that the AUC of nCD64, IL-6 and PCT predicting the prognosis of sepsis at each time point ranged from 0.600 to 0.981. The clearance rates of nCD64, IL-6 and PCT at 3 and 7 days after ICU admission were calculated by dividing the difference between the 1st and 3rd or 7th days after entering the ICU by the value at the 1st day. Logistic regression was used to analyze their predictive value for the prognosis of sepsis. The results showed that the clearance rates of nCD64, IL-6 and PCT on the 3rd and 7th day of ICU were protective factors for 28-day mortality in patients with sepsis, except the clearance rate of IL-6 on the 7th day.

CONCLUSIONS: nCD64, IL-6 and PCT have good value as biomarkers for the diagnosis of sepsis. The diagnostic value of nCD64 is higher than that of PCT and IL-6. When they are used together, the diagnostic value is the highest. nCD64, IL-6 and PCT have certain value in evaluating the severity and predicting the prognosis of patients with sepsis. The higher the clearance rate of nCD64, IL-6 and PCT, the lower the 28-day mortality risk of patients with sepsis.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Li X, Wang J. [Diagnostic and prognostic value of neutrophil CD64, IL-6, and PCT in ICU patients with sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 37308224. doi:10.3760/cma.j.cn121430-20230112-00021

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。